Chairman emeritus Peter C. Farrell - 05 Mar 2025 Form 4 Insider Report for RESMED INC (RMD)

Role
Director
Signature
Peter C. Farrell, Chairman emeritus
Issuer symbol
RMD
Transactions as of
05 Mar 2025
Net transactions value
-$455,420
Form type
4
Filing time
06 Mar 2025, 17:40:28 UTC
Previous filing
05 Feb 2025
Next filing
04 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale $455,420 -2,000 -2.6% $227.71 75,218 05 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan adopted May 28, 2024